Portal de investigación
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Chaparro M
- Ordás I
- Cabré E
- Garcia-Sanchez V
- Peñalva M
- Gomollón F
- García-Planella E
- Merino O
- Gutiérrez A
- Esteve M
- Márquez L
- Garcia-Sepulcre M
- Vera I
- Muñoz F
- Mendoza JL
- Cabriada JL
- Montoro MA
- Barreiro-de Acosta M
- Ceña G
- Saro C
- Aldeguer X
- Barrio J
- Maté J
- Gisbert JP
Grupos
Abstract
To evaluate the safety of thiopurines in patients with inflammatory bowel disease. To identify predictive factors associated with the development of thiopurine-induced adverse events.
Datos de la publicación
- ISSN/ISSNe:
- 1078-0998, 1536-4844
- Tipo:
- Article
- Páginas:
- 1404-1410
- PubMed:
- 23665964
- Factor de Impacto:
- 2,863 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
INFLAMMATORY BOWEL DISEASES OXFORD UNIV PRESS INC
Citas Recibidas en Web of Science: 246
Documentos
- No hay documentos
Filiaciones
Campos de Estudio
Cita
Chaparro M,Ordás I,Cabré E,Garcia V,BASTIDA G,Peñalva M,Gomollón F,García E,Merino O,Gutiérrez A,Esteve M,Márquez L,Garcia M,HINOJOSA J,Vera I,Muñoz F,Mendoza JL,Cabriada JL,Montoro MA,Barreiro M,Ceña G,Saro C,Aldeguer X,Barrio J,Maté J,Gisbert JP. Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients. Inflamm. Bowel Dis. 2013. 19. (7):p. 1404-1410. IF:5,475. (1).